The global automated nucleic acid extraction market size was valued at US$ 3.6 Bn in 2025 and is projected to reach US$ 11.7 ...

IARI have developed a highly sensitive, field-deployable LAMP assay that identifies the invasive melon fly in under an hour ...

The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive ...

Court's Decision on COVID-19 Compensation Claims The Mumbai High Court has ruled that a compensation application filed after ...

The Bombay High Court has ruled that a negative RTPCR report cannot be the sole reason to deny COVID-19 compensation. The ...

Measles, which was declared to be eliminated in 2000 in the United States, has seen a resurgence, with more than 2,000 cases ...

Point-of-care testing for common sexually transmitted infections may reduce overuse of antibiotics and improve emergency ...

Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its 2026 priorities across its five growth pillars focused on advancing product commercialization, regulatory milestones and ...

According to Brain Chemistry Labs, the in-the-works test can identify an ALS patient with 97% accuracy. The next step is to ...

GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...

FLGT currently has a market capitalization of $853.49 million.